Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$1.18 - $1.91 $17,700 - $28,650
-15,000 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$1.01 - $2.78 $15,150 - $41,700
15,000 New
15,000 $17,000
Q3 2018

Nov 14, 2018

SELL
$1.72 - $2.71 $44,548 - $70,189
-25,900 Closed
0 $0
Q2 2018

Aug 10, 2018

SELL
$1.72 - $2.26 $4,644 - $6,101
-2,700 Reduced 9.44%
25,900 $49,000
Q1 2018

May 15, 2018

BUY
$1.8 - $2.74 $51,480 - $78,364
28,600 New
28,600 $60,000
Q4 2017

Feb 14, 2018

SELL
$1.22 - $3.73 $56,608 - $173,072
-46,400 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$0.94 - $1.35 $43,616 - $62,640
46,400
46,400 $61,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.